Advertisement

Lack of activation of the S113L variant of carnitine palmitoyltransfersase II by cardiolipin

  • Leila Motlagh ScholleEmail author
  • Annemarie Thaele
  • Marie Beckers
  • Beate Meinhardt
  • Stephan Zierz
Article
  • 34 Downloads

Abstract

The phospholipid environment of the mitochondrial inner membrane, which contains large amounts of cardiolipin, could play a key role in transport of the long chain fatty acids. In the present study, the pre-incubation of cardiolipin with the wild type carnitine palmitoyltransferase (CPT) II led to a more than 1.5-fold increase of enzyme activity at physiological temperatures. At higher temperatures, however, there was a pronounced loss of activity. The most frequent variant S113L showed even at 37 °C a great activity loss. Pre-incubation of the wild type with both malonyl-CoA and cardiolipin counteracted the positive effect of cardiolipin. Malonyl-CoA, however, showed no inhibition effect on the variant in presence of cardiolipin. The activity loss in presence of cardiolipin at fever simulating situations was more pronounced for the variant comparing to the wild type. The reason might be a disturbed membrane association or a blockage of the active center of the mutated enzyme.

Keywords

CPT II deficiency Cardiolipin Membrane association Enzyme activity 

Abbreviations

CACT

carnitine / acylcarnitine translocase

CoA

Coenzyme A

CPT

carnitine palmitoyltransferase

DTNB

5,5΄-dithio-bis-(2-nitrobenzoic acid)

hCPT2

gene coding for human muscle carnitine palmitoyltransferase II

MIM

inner mitochondrial membrane

MOM

outer mitochondrial membrane

Notes

Author contributions

LMS, AT, MB & BM carried out the lab work and data analysis; LMS and SZ designed the study and drafted the manuscript. All authors gave final approval for publication.

Funding

This work was supported by the Deutsche Gesellschaft für Muskelkranke (DGM) e.V.

(www.dgm.org).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Molecular biology of the cell. Garland Science, New YorkGoogle Scholar
  2. Comte J, Maisterrena B, Gautheron DC (1976) Lipid composition and protein profiles of outer and inner membranes from pig heart mitochondria. Comparison with microsomes. Biochim Biophys Acta 419:271–284CrossRefGoogle Scholar
  3. Dowhan W (1997) Molecular basis for membrane phospholipid diversity: why are there so many lipids? Annu Rev Biochem 66:199–232.  https://doi.org/10.1146/annurev.biochem.66.1.199 CrossRefPubMedGoogle Scholar
  4. Fraser F, Padovese R, Zammit VA (2001) Distinct kinetics of carnitine palmitoyltransferase i in contact sites and outer membranes of rat liver mitochondria. J Biol Chem 276:20182–20185CrossRefGoogle Scholar
  5. Hoch FL (1992) Cardiolipins and biomembrane function. Biochim Biophys Acta 1113:71–133CrossRefGoogle Scholar
  6. Kashfi K, Mynatt RL, Park EA, Cook GA (2011) Membrane microenvironment regulation of carnitine palmitoyltranferases I and II. Biochem Soc Trans 39:833–837CrossRefGoogle Scholar
  7. Kerner J, Hoppel C (2000) Fatty acid import into mitochondria. Biochim Biophys Acta 1486:1–17CrossRefGoogle Scholar
  8. McGarry JD, Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1–14CrossRefGoogle Scholar
  9. Motlagh L, Golbik R, Sippl W, Zierz S (2016a) Malony-CoA inhibits the S113L variant of carnitine-palmitoyltransferase II. Biochim Biophys Acta 1861:34–40.  https://doi.org/10.1016/j.bbalip.2015.10.005 CrossRefPubMedGoogle Scholar
  10. Motlagh L, Golbik R, Sippl W, Zierz S (2016b) Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II. Neurol Genet 2:e53CrossRefGoogle Scholar
  11. Mynatt RL, Greenhaw JJ, Cook GA (1994) Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids. Biochem J 299(Pt 3):761–767CrossRefGoogle Scholar
  12. Paradies G, Paradies V, De Benedictis V, Ruggiero FM, Petrosillo G (2014) Functional role of cardiolipin in mitochondrial bioenergetics. Biochim Biophys Acta 1837:408–417CrossRefGoogle Scholar
  13. Planas-Iglesias J, Dwarakanath H, Mohammadyani D, Yanamala N, Kagan VE, Klein-Seetharaman J (2015) Cardiolipin interactions with proteins. Biophys J 109:1282–1294CrossRefGoogle Scholar
  14. Schlame M, Haldar D (1993) Cardiolipin is synthesized on the matrix side of the inner membrane in rat liver mitochondria. J Biol Chem 268:74–79PubMedGoogle Scholar
  15. Woeltje KF, Kuwajima M, Foster DW, McGarry JD (1987) Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. J Biol Chem 262:9822–9827PubMedGoogle Scholar
  16. Woldegiorgis G, Bremer J, Shrago E (1985) Substrate inhibition of carnitine palmitoyltransferase by palmitoyl-CoA and activation by phospholipids and proteins. Biochim Biophys Acta 837:135–140CrossRefGoogle Scholar
  17. Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem 149:207–214CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Leila Motlagh Scholle
    • 1
    Email author
  • Annemarie Thaele
    • 1
  • Marie Beckers
    • 1
  • Beate Meinhardt
    • 1
  • Stephan Zierz
    • 1
  1. 1.Department of NeurologyMartin Luther University Halle-WittenbergHalle (Saale)Germany

Personalised recommendations